.svg)
.svg)
.svg)
May 28, 2026
Focalyx® at AUA 2026: Showcasing precision and minimally invasive prostate cancer treatment to enhance patient quality of life.
Article content
Focalyx® was present at AUA 2026, one of the world's leading urology events.
📍 Washington, DC
📅 May 15–18
Booth #1109
At this event, we shared our vision for prostate cancer treatment: a precision-based, minimally invasive approach that prioritizes the patient's quality of life.
It was an excellent opportunity to connect with specialists, learn more about our Focalyx® Fusion technology, and explore how we are redefining prostate cancer management.
.svg){kind=logo}
.svg){kind=logo}
